Nature Communications (Mar 2021)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques

  • Hyon-Xhi Tan,
  • Jennifer A. Juno,
  • Wen Shi Lee,
  • Isaac Barber-Axthelm,
  • Hannah G. Kelly,
  • Kathleen M. Wragg,
  • Robyn Esterbauer,
  • Thakshila Amarasena,
  • Francesca L. Mordant,
  • Kanta Subbarao,
  • Stephen J. Kent,
  • Adam K. Wheatley

DOI
https://doi.org/10.1038/s41467-021-21665-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

Current vaccine strategies for SARS-CoV-2 focus on eliciting neutralising antibodies to the spike protein (S), but differences in immunogenicity of full-length S versus receptor binding domain (RBD) only aren’t fully understood. Here, the authors show immunogenicity of different prime-boost strategies with S and/or RBD in mice and macaques.